2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC).
Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC).
In the future, researchers hope to see an increased utilization of partial nephrectomy and a more sensible utilization of radical nephrectomy, states Campbell.
Many are advocating for a utility-based approach to renal mass biopsy, meaning it will only be applied to patients who might have their treatment management changed, explains Campbell.
Related Content: